1. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions
   Tomas Koltai et al, 2022, Journal of Evidence-Based Integrative Medicine CrossRef
2. Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
   Julieta Afonso et al, 2023, Cancers CrossRef
3. New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles
   Keyvan Khazei et al, 2021, Current Cancer Drug Targets CrossRef
4. Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer
   Yi-Fang Yang et al, 2021, International Journal of Molecular Sciences CrossRef
5. Silibinin Prevents TGFβ-Induced EMT of RPE in Proliferative Vitreoretinopathy by Inhibiting Stat3 and Smad3 Phosphorylation
   Xinqi Ma et al, 2023, Investigative Opthalmology & Visual Science CrossRef
6. Natural Phytochemicals in Bladder Cancer Prevention and Therapy
   Yong Xia et al, 2021, Frontiers in Oncology CrossRef
7. Total phenolic content, free radical scavenging capacity, and anti-cancer activity of silymarin
   Uyory Choe et al, 2020, Journal of Food Bioactives CrossRef
8. Oxidative stress in bladder cancer: an ally or an enemy?
   Fernando Mendes et al, 2021, Molecular Biology Reports CrossRef
9. Chromene-based compounds as drug candidates for renal and bladder cancer therapy – A systematic review
   Mónica Costa Cerqueira et al, 2024, Bioorganic Chemistry CrossRef
10. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
    Julieta Afonso et al, 2020, Nature Reviews Urology CrossRef
11. De-methylation of miR-148a by arsenic trioxide enhances sensitivity to chemotherapy via inhibiting the NF-κB pathway and CSC like properties
    Yuting Wang et al, 2020, Experimental Cell Research CrossRef
12. Anti-cancer Effects of Silibinin: The Current Status in Cancer Chemoprevention
    Dominique Reed et al, 2020, Natural Products for Cancer Chemoprevention CrossRef